IVVN
Login
Register
Contact
Newsletter
Search
Search
Search
Toggle main menu visibility
About us
Network vision
Network funders
Other Vaccine Networks
Annual Reports
Annual Report 2018
Annual Report 2019
Annual Report 2020
Annual Report 2021
Annual Report 2022
Background
Activities
Structure
Membership
Webinars
Survey results
Outreach
Fellowship programme
Online workshop
Catalyst funding
Equality and inclusivity statement
Members
Membership benefits
Network Management Team
Network Management Board
External Advisory Group
News
Newsletters
Blog
Events
Annual conferences
Vietnam 2024
Presentations
Nairobi 2018
Hanoi 2020
London 2019
GCRF Networks Vaccinology Course
Presentations
Scholars
Workshops
Past workshops
IVVN Virtual Symposia
IVVN webinars
Training
Online Training Courses
IVVN Early Career Researcher Event
Funding
Pump-priming grants
Funded projects
IVVN ECR Career Development Fellowship Scheme
Laboratory exchange awards
Funded projects
Fellowship programme
Funded projects
Funding opportunities
Privacy statement
Job Vacancies
Publications
Useful Links
Home
Resources & Peer-reviewed publications
Resources & Peer-reviewed publications
1
Keywords
From
From
Year
-Year
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
To
To
Year
-Year
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Year
- Any -
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
1991
1975
Tags
- Any -
AWARD
Adenovirus
Adjuvants
Aeromonas
African swine fever
Anthrax
Atadenovirus
Autogenous vaccines
Babesia
Bluetongue
Bovine viral diarrhea
Brucella
Campylobacter
Cattle vaccines
Chlamydia abortus
Classical swine fever
Clostridium
Coccidiosis
Coronavirus
DIVA vaccines
Diagnostic tests
E. coli
ELISA
Echinococcosis
Ectoparasites
Editorials
Edwardsiella
Ehrlichia
Eimeria
Fish vaccines
Foot-and-mouth disease
Gene editing
Glycoengineering
Haemorrhagic septicemia
Helminths
Hepatitis E
Herpesvirus
IVVN online training
IVVN online training 2022
Infectious bronchitis disease
Infectious bursal disease virus
Influenza
Leptospira
Malaria
Manufacture
Marek's disease
Meeting report
Morbillivirus
Mucosal vaccines
Mycoplasma
Nanoparticles
Nematodes
Newcastle disease
Nipah
Nucleic acid vaccines
One Health
Opinion articles
Orthoavulavirus
Papillomavirus
Parainfluenza
Paramyxovirus
Paratuberculosis
Pasteurella
Peste des petits ruminants
Plant production
Policy
Porcine circovirus
Porcine epidemic diarrhoea virus
Porcine reproductive and respiratory syndrome
Poultry vaccines
Poxviruses
Protocols
Pseudorabies
Q fever
Rabies
Respiratory syncytial virus
Review articles
Rift Valley fever
Salmonella
Small ruminant vaccines
Staphylococcus
Streptococcus
Subunit vaccines
Swine vaccines
T cell immunity
Taenia solium
Theileria
Tilapia lake virus
Tools
Trypanosoma
Tuberculosis
Vectored vaccines
Vibriosis
Virus-like particles
Wildlife vaccines
Yersinia
Zoonoses
article
closed_funding
closed_jobs
covid-19
covid-19 articles
covresources
covwebinar
fundingopps
ivvn virtual events
jobs
past training
publication
undefined
upcoming training
webinar-2023
webinar-2025
webinar-agresults
webinars
workshop
Resource type
- Any -
Article
Book chapter
Funding
Peer-reviewed article
Podcast episode
Report
Resource
Training
Vacancy
Video
Webinar
Workshop
Source
- Any -
01 Dec 2025
Immunogenicity, security and protection against small ruminant lentivirus (SRLV) challenge in sheep, induced by intranasal immunization with a recombinant Sendai virus vector expressing SRLV gag-P25.
01 Dec 2025
A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector.
01 Dec 2025
A lineage 1 branch porcine reproductive and respiratory syndrome virus live vaccine candidate provides broad cross-protection against HP-like PRRSV in piglets.
Closes: 1 February 2026
The sub-Saharan Africa Health Research and Innovation Fellowship Program (SAHRI Fellowship)
The SAHRI Fellowship programme is an exceptional three-year training trajectory designed to empower 12 talented mid-career biomedical and clinical researchers from sub-Saharan Africa (sSA) to become leaders in biomedical innovation and clinical research.
Closes: 29 September 2025
Innovation Facilitator
This role will aid VMD to transition to a more proactive approach to innovation, ensuring that its regulatory frameworks and guidance evolve to enable new technologies, and that this guidance is accessible to innovators.
27 Sep 2025
Foot-and-mouth disease vaccine with insertion of a 24-amino acid VP1 G-H loop epitope of the Cathay virus provides broad antigenic coverage.
27 Sep 2025
T cell-mediated clearance of porcine reproductive and respiratory syndrome virus (PRRSV) from the lung characterized by machine learning analysis in vaccinated and unvaccinated pigs.
Closes: 5 November 2025
Head of Science Strategy
We are seeking an exceptional research-active leader to become Head of Science Strategy at The Pirbright Institute. This is a unique opportunity to combine your own world-class research programme with a senior strategic leadership role at one of the UK’s most important bioscience institutes.
23 Sep 2025
Adjuvant screening of an inactivated Pasteurella multocida vaccine in mice and evaluation of its immunogenicity in sheep.
22 Sep 2025
A Simple Deterministic Model of Protection and Cost Benefits from Vaccinating Indian Cattle Against Infectious Bovine Rhinotracheitis.
22 Sep 2025
A Novel Chimeric Fiber-C4/D11 Subunit Vaccine Induces Cross-Neutralizing Antibodies and Provides Better Protection Against Fowl Adenovirus (FAdV) Type 4 and Type 11 Than the Fiber-D11/C4 Subunit Vaccine.
Closes: 31 October 2025
MRC Impact Accelerator Account - Round 4
The MRC Impact Accelerator Account (IAA) scheme provides funding to institutions to support the earliest stages of translational research projects.
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »
1
Keywords
From
From
Year
-Year
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
To
To
Year
-Year
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Year
- Any -
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
1991
1975
Tags
- Any -
AWARD
Adenovirus
Adjuvants
Aeromonas
African swine fever
Anthrax
Atadenovirus
Autogenous vaccines
Babesia
Bluetongue
Bovine viral diarrhea
Brucella
Campylobacter
Cattle vaccines
Chlamydia abortus
Classical swine fever
Clostridium
Coccidiosis
Coronavirus
DIVA vaccines
Diagnostic tests
E. coli
ELISA
Echinococcosis
Ectoparasites
Editorials
Edwardsiella
Ehrlichia
Eimeria
Fish vaccines
Foot-and-mouth disease
Gene editing
Glycoengineering
Haemorrhagic septicemia
Helminths
Hepatitis E
Herpesvirus
IVVN online training
IVVN online training 2022
Infectious bronchitis disease
Infectious bursal disease virus
Influenza
Leptospira
Malaria
Manufacture
Marek's disease
Meeting report
Morbillivirus
Mucosal vaccines
Mycoplasma
Nanoparticles
Nematodes
Newcastle disease
Nipah
Nucleic acid vaccines
One Health
Opinion articles
Orthoavulavirus
Papillomavirus
Parainfluenza
Paramyxovirus
Paratuberculosis
Pasteurella
Peste des petits ruminants
Plant production
Policy
Porcine circovirus
Porcine epidemic diarrhoea virus
Porcine reproductive and respiratory syndrome
Poultry vaccines
Poxviruses
Protocols
Pseudorabies
Q fever
Rabies
Respiratory syncytial virus
Review articles
Rift Valley fever
Salmonella
Small ruminant vaccines
Staphylococcus
Streptococcus
Subunit vaccines
Swine vaccines
T cell immunity
Taenia solium
Theileria
Tilapia lake virus
Tools
Trypanosoma
Tuberculosis
Vectored vaccines
Vibriosis
Virus-like particles
Wildlife vaccines
Yersinia
Zoonoses
article
closed_funding
closed_jobs
covid-19
covid-19 articles
covresources
covwebinar
fundingopps
ivvn virtual events
jobs
past training
publication
undefined
upcoming training
webinar-2023
webinar-2025
webinar-agresults
webinars
workshop
Resource type
- Any -
Article
Book chapter
Funding
Peer-reviewed article
Podcast episode
Report
Resource
Training
Vacancy
Video
Webinar
Workshop
Source
- Any -
01 Dec 2025
Immunogenicity, security and protection against small ruminant lentivirus (SRLV) challenge in sheep, induced by intranasal immunization with a recombinant Sendai virus vector expressing SRLV gag-P25.
01 Dec 2025
A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector.
01 Dec 2025
A lineage 1 branch porcine reproductive and respiratory syndrome virus live vaccine candidate provides broad cross-protection against HP-like PRRSV in piglets.
Closes: 1 February 2026
The sub-Saharan Africa Health Research and Innovation Fellowship Program (SAHRI Fellowship)
The SAHRI Fellowship programme is an exceptional three-year training trajectory designed to empower 12 talented mid-career biomedical and clinical researchers from sub-Saharan Africa (sSA) to become leaders in biomedical innovation and clinical research.
Closes: 29 September 2025
Innovation Facilitator
This role will aid VMD to transition to a more proactive approach to innovation, ensuring that its regulatory frameworks and guidance evolve to enable new technologies, and that this guidance is accessible to innovators.
27 Sep 2025
Foot-and-mouth disease vaccine with insertion of a 24-amino acid VP1 G-H loop epitope of the Cathay virus provides broad antigenic coverage.
27 Sep 2025
T cell-mediated clearance of porcine reproductive and respiratory syndrome virus (PRRSV) from the lung characterized by machine learning analysis in vaccinated and unvaccinated pigs.
Closes: 5 November 2025
Head of Science Strategy
We are seeking an exceptional research-active leader to become Head of Science Strategy at The Pirbright Institute. This is a unique opportunity to combine your own world-class research programme with a senior strategic leadership role at one of the UK’s most important bioscience institutes.
23 Sep 2025
Adjuvant screening of an inactivated Pasteurella multocida vaccine in mice and evaluation of its immunogenicity in sheep.
22 Sep 2025
A Simple Deterministic Model of Protection and Cost Benefits from Vaccinating Indian Cattle Against Infectious Bovine Rhinotracheitis.
22 Sep 2025
A Novel Chimeric Fiber-C4/D11 Subunit Vaccine Induces Cross-Neutralizing Antibodies and Provides Better Protection Against Fowl Adenovirus (FAdV) Type 4 and Type 11 Than the Fiber-D11/C4 Subunit Vaccine.
Closes: 31 October 2025
MRC Impact Accelerator Account - Round 4
The MRC Impact Accelerator Account (IAA) scheme provides funding to institutions to support the earliest stages of translational research projects.
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »